Search
for
Sort by
Research 61–90 of 122
- Hypogonadism as a Reversible Cause of Torsades de Pointes in Men
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- Coronavirus Infection and Cholesterol Metabolism
- Targeting integrin pathways: mechanisms and advances in therapy
- Functional Enhancers As Master Regulators of Tissue-Specific Gene Regulation and Cancer Development.
- What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
- Cardiovascular Toxicities of Androgen Deprivation Therapy
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- PROTACs: A novel strategy for cancer drug discovery and development
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride
- Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia
- Androgen Receptor Mutations and Polymorphisms in African American Prostate Cancer
- Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- The immune response to COVID‐19: Does sex matter?
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- COVID-19 in Africa: an ovarian victory?
- Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
- Roles of steroid receptors in the lung and COVID-19
- Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
- Impact of Medical Castration on Malignant Arrhythmias in Patients With Prostate Cancer
- Development of a Carvedilol-Loaded Solid Self-Nanoemulsifying System with Increased Solubility and Bioavailability Using Mesoporous Silica Nanoparticles
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol